Imbruvica (ibrutinib) - AbbVie, J&J
Calquence (acalabrutinib) - AstraZeneca
rocbrutinib (LP-168) - Lupeng Pharma
Inokai (orelabrutinib) - Zenas BioPharma
Brukinsa (zanubrutinib) - BeOne Medicines
http://clinicaltrials.gov/ct2/show/NCT07377578
 
Feb 1, 2026
 
Next